How GLP-1s are transforming binge eating and big food
Leslie Schrock
8 min read
An unexpected consequence of these blockbuster drugs
All Articles
Making sense of healthcare deals, technology, policy, and the occasional industry curveball.
23andMe should have raised less capital
Christina Farr
6 min read
My takeaway from today’s news that the company is filing for bankruptcy
4 questions on the future of employer-sponsored healthcare
Christina Farr
7 min read
What is keeping employers up at night going into 2025? A conversation with Chris Michalak
Why the Hinge Health IPO is so important for digital health
Christina Farr
6 min read
A few thoughts...
Why is longevity suddenly so hot?
Christina Farr
9 min read
Between Function Health, Lifeforce and Superpower, this space is on fire
Is health-tech entering its ‘influencer’ era?
Christina Farr
7 min read
And what are the pros and cons?
4 questions on President Trump and IVF
Christina Farr
4 min read
I caught up with Conceivable Life Sciences’ Joshua Abram to understand the political landscape and its impact on reproductive health
Care delivery in all 50 states? No longer as common as it used to be
Christina Farr
4 min read
Some digital health companies are getting more targeted with their approach
The massive opportunity in women's longevity
Leslie Schrock
14 min read
State of the union, and where we go from here
There’s a new game in town for D2C health business models
Christina Farr
7 min read
And it’s rapidly evolving in real time!
How are employers going to pay for cell and gene therapies?
Christina Farr
6 min read
Let’s get real about the alliance between U.S. health care and employment
The formula for a productive investor update email
Christina Farr
7 min read
Because so many of you asked for it!